MicroRNA-193a-3p as a Valuable Biomarker for Discriminating between Colorectal Cancer and Colorectal Adenoma Patients
Authors:
- Marija FabijanecMFMarija Fabijanec
- Andrea Hulina-TomaškovićAHAndrea Hulina-Tomašković
- Mario ŠtefanovićMŠMario Štefanović
- Donatella VerbanacDonatella Verbanac
- Ivana ĆelapIĆIvana Ćelap
- Anita Somborac-BačuraASAnita Somborac-Bačura
- Marija Grdić RajkovićMRMarija Grdić Rajković
- Alma DemirovićADAlma Demirović
- Snježana RamićSRSnježana Ramić
- Božo KrušlinBKBožo Krušlin
- Lada RumoraLRLada Rumora
- Andrea ČeriAČAndrea Čeri
Open Access
- 26 July 2024
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (15) , 8156
Abstract
Specific markers for colorectal cancer (CRC), preceded by colorectal adenoma (pre-CRC), are lacking. This study aimed to investigate whether microRNAs (miR-19a-3p, miR-92a-3p, miR-193a-3p, and miR-210-3p) from tissues and exosomes are potential CRC biomarkers and compare them to existing biomarkers, namely carcinoembryonic antigen (CEA) and carbohydrate antigen (CA) 19-9. MiRNA was isolated in the samples of 52 CRC and 76 pre-CRC patients. Expression levels were analyzed by RT-qPCR. When comparing pre-CRC and CRC tissue expression levels, only miR-193a-3p showed statistically significant result (p < 0.0001). When comparing the tissues and exosomes of CRC samples, a statistically significant difference was found for miR-193a-3p (p < 0.0001), miR-19a-3p (p < 0.0001), miR-92a-3p (p = 0.0212), and miR-210-3p (p < 0.0001). A receiver-operating characteristic (ROC) curve and area under the ROC curve (AUC) were used to evaluate the diagnostic value of CEA, CA 19-9, and miRNAs. CEA and CA 19-9 had good diagnostic values (AUCs of 0.798 and 0.668). The diagnostic value only of miR-193a-3p was highlighted (AUC = 0.725). The final logistic regression model, in which we put a combination of CEA concentration and the miR-193a-3p expression level in tissues, showed that using these two markers can distinguish CRC and pre-CRC in 71.3% of cases (AUC = 0.823). MiR-193a-3p from tissues could be a potential CRC biomarker.Keywords
Funding Information
- Hrvatska Zaklada za Znanost (IP-2019-04-4624, KK.01.1.1.02.0021, KK.01.1.1.02-0014)
- European Regional Development Fund (IP-2019-04-4624, KK.01.1.1.02.0021, KK.01.1.1.02-0014)
This publication has 48 references indexed in Scilit:
- The prognostic significant of percentage drop in serum CEA post curative resection for colon cancerSurgical Oncology, 2012
- miR‐92 is a key oncogenic component of the miR‐17–92 cluster in colon cancerCancer Science, 2011
- A Diagnostic Assay Based on MicroRNA Expression Accurately Identifies Malignant Pleural MesotheliomaThe Journal of Molecular Diagnostics, 2010
- Over- and under-expressed microRNAs in human colorectal cancerInternational Journal of Oncology, 2009
- Diagnostic precision of carcinoembryonic antigen in the detection of recurrence of colorectal cancerSurgical Oncology, 2009
- Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screeningGut, 2009
- Exploration of Tumor-Suppressive MicroRNAs Silenced by DNA Hypermethylation in Oral CancerCancer Research, 2008
- Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical useEuropean Journal of Cancer, 2007
- ASCO 2006 Update of Recommendations for the Use of Tumor Markers in Gastrointestinal CancerJournal of Clinical Oncology, 2006
- MicroRNAsCell, 2004